13 Anti-thymocyte globulin (ATG) vs. Basiliximab induction in renal transplant recipients: A long term outcome
نویسندگان
چکیده
منابع مشابه
Relationship between post-transplant lymphoproliferative disorder and Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin
Abstract Background: Lymphoproliferative disorders are among the most serious and potentially fatal complications of chronic immunosuppression in kidney transplant recipients. The principle risk factors for development of PTLD are the degree of overall immunosuppression and the EBV serostatus of the recipient. In this study, the risk of PTLD in kidney transplant recipients who received Anti- L...
متن کاملUse of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipients.
Kidney transplant remains the best type of renal replacement therapy in most patients with end-stage kidney disease, even in those with high immunologic risk. Immunosuppression in these patients is regarded as more complex, owing to the higher risk of both acute and chronic rejection. The advent of induction immunosuppression has resulted in a lower incidence of acute rejection and consequently...
متن کاملComparison of Induction Therapy Using Anti-thymocyte Globulin and Using Basiliximab for Live Donor Kidney Transplant Recipients: a Single-center, Prospective, Cohort Study
Objective: Acute rejections (ARs) have a negative impact on long-term graft survival and are the major predictor of chronic rejection. Induction therapy is used to reduce AR and prevent delayed graft function (DGF). Anti-thymocyte globulin (ATG) and basiliximab are mainly used for this purpose. In this prospective, cohort study, we analyzed and compared the safety and efficacy of ATG and basili...
متن کاملComparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis
BACKGROUND Basiliximab and anti-thymocyte globulin are widely used drugs for induction therapy after pediatric heart transplantation. The aim of this study was to determine whether any differences could be observed between basiliximab and anti-thymocyte globulin, with respect to long-term mortality, in a population of pediatric cardiac transplant recipients. METHODS AND RESULTS An analysis of...
متن کاملImpaired glucose homeostasis in renal transplant recipients receiving basiliximab.
BACKGROUND The pathogenesis of new onset diabetes after transplantation (NODAT) is multifactorial. Suppression of regulatory T lymphocytes may have a negative impact on pancreatic beta-cells. Induction with basiliximab affects regulatory T-cell function and may therefore, theoretically, also affect glucose homeostasis in renal transplant recipients. METHODS All kidney recipients > or =50 year...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Transplantation
سال: 2011
ISSN: 2212-0017
DOI: 10.1016/s2212-0017(11)60017-8